Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: J Cancer Res Clin Oncol. 2013 Sep 3;139(10):10.1007/s00432-013-1501-6. doi: 10.1007/s00432-013-1501-6

Figure 3. Microarray analysis of high frequency autoantibodies.

Figure 3

Individual serum samples from ovarian cancer, benign ovarian disease and healthy individuals were screened on a microarray containing recombinant CFL1, EZR, PDZ and TUBA1C autoantigens and influenza HA protein as controls. The average spot density generated by GenPix microarray reader is plotted for each of the autoantigens.